IDEX Biometrics (IDEX) Q3 2025 earnings summary

Executive summary

• Achieved transformation from component supplier to product company, launching certified biometric access and payment card products.

• Achieved four out of five strategic objectives set in March 2025, with the fifth (sales exceeding OpEx) targeted for Q4.

• Streamlined operations and reduced operating expenses significantly, with further improvements underway.

• Secured new contracts post-Q3 with Toshiba, Emnovate, and ACS, with further volume expected in Q1 2026.

• Maintained strong market position in payment cards and advanced toward generating sales exceeding operating expenses by year-end.

Financial highlights

• Operating expenses reduced to $1.8M in Q3 2025, a 60% decrease versus Q3 2024 and 62% lower than the 2024 quarterly average of $4.6M.

• Q3 2025 revenue was $0.0 million, down from $0.1 million in Q3 2024; YTD revenue was $0.2 million, down from $0.8 million YTD 2024.

• Net loss for Q3 2025 was $1.0 million, compared to a net gain of $1.4 million in Q3 2024; YTD net loss was $7.2 million, improved from $10.7 million YTD 2024.

• Achieved over $8-10 million in annualized operating cost savings through restructuring.

• Cash balance at September 30, 2025, was $1.1 million, unchanged from a year earlier.

Outlook and guidance

• Further OPEX reductions expected: ~$150K in Q4 2025 and ~$250K per quarter from 2026.

• Anticipates initial contract orders in Q4 2025 and accelerating volume in Q1 2026 as product certifications complete.

• Positioned to achieve profitability at lower revenue levels due to significant cost reductions.

• Expects to meet the target of generating sales exceeding OpEx on a monthly basis by year-end.